S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.42 (+0.90%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.42 (+0.90%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
Log in

Regeneron Pharmaceuticals News Headlines (NASDAQ:REGN)

$298.08
-2.11 (-0.70 %)
(As of 10/21/2019 04:00 PM ET)
Today's Range
$294.86
Now: $298.08
$301.97
50-Day Range
$273.46
MA: $288.14
$308.15
52-Week Range
$271.37
Now: $298.08
$442.00
Volume497,675 shs
Average Volume770,000 shs
Market Capitalization$32.74 billion
P/E Ratio15.05
Dividend YieldN/A
Beta1.14

Headlines

Regeneron Pharmaceuticals (NASDAQ REGN) News Headlines

Source:
DateHeadline
Zacks: Analysts Expect Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Will Post Quarterly Sales of $1.96 BillionZacks: Analysts Expect Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Will Post Quarterly Sales of $1.96 Billion
www.americanbankingnews.com - October 20 at 6:56 AM
Zacks: Analysts Expect Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Will Post Earnings of $6.26 Per ShareZacks: Analysts Expect Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Will Post Earnings of $6.26 Per Share
www.americanbankingnews.com - October 18 at 5:20 AM
Consort Medical Signs VapourSoft Development Agreement With RegeneronConsort Medical Signs VapourSoft Development Agreement With Regeneron
www.lse.co.uk - October 18 at 4:28 AM
Regeneron Pharmaceuticals (NASDAQ:REGN) Now Covered by Analysts at Bank of AmericaRegeneron Pharmaceuticals (NASDAQ:REGN) Now Covered by Analysts at Bank of America
www.americanbankingnews.com - October 16 at 5:58 PM
Regeneron Pharmaceuticals (NASDAQ:REGN) Given a $344.00 Price Target at BMO Capital MarketsRegeneron Pharmaceuticals (NASDAQ:REGN) Given a $344.00 Price Target at BMO Capital Markets
www.americanbankingnews.com - October 11 at 6:17 PM
Regeneron Pharmaceuticals (NASDAQ:REGN) PT Set at $435.00 by Piper Jaffray CompaniesRegeneron Pharmaceuticals (NASDAQ:REGN) PT Set at $435.00 by Piper Jaffray Companies
www.americanbankingnews.com - October 11 at 6:17 PM
Regeneron Pharmaceuticals (NASDAQ:REGN) Given a $349.00 Price Target at CowenRegeneron Pharmaceuticals (NASDAQ:REGN) Given a $349.00 Price Target at Cowen
www.americanbankingnews.com - October 11 at 6:17 PM
Hedge Funds Have Never Been This Bullish On Regeneron Pharmaceuticals Inc (REGN)Hedge Funds Have Never Been This Bullish On Regeneron Pharmaceuticals Inc (REGN)
finance.yahoo.com - October 10 at 9:55 PM
Novartis' (NVS) Wet AMD Drug Beovu Obtains FDA ApprovalNovartis' (NVS) Wet AMD Drug Beovu Obtains FDA Approval
finance.yahoo.com - October 9 at 11:55 AM
Canaccord Genuity Reaffirms "Hold" Rating for Regeneron Pharmaceuticals (NASDAQ:REGN)Canaccord Genuity Reaffirms "Hold" Rating for Regeneron Pharmaceuticals (NASDAQ:REGN)
www.americanbankingnews.com - October 9 at 11:12 AM
Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Excessively Paying Its CEO?Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Excessively Paying Its CEO?
finance.yahoo.com - October 1 at 5:04 PM
Regeneron Priced Right For Long-Term InvestorsRegeneron Priced Right For Long-Term Investors
seekingalpha.com - September 27 at 8:44 PM
$1.95 Billion in Sales Expected for Regeneron Pharmaceuticals Inc (NASDAQ:REGN) This Quarter$1.95 Billion in Sales Expected for Regeneron Pharmaceuticals Inc (NASDAQ:REGN) This Quarter
www.americanbankingnews.com - September 27 at 2:40 AM
Biotech Stock Roundup: Pipeline Updates From REGN, BIIB, AMGN and MoreBiotech Stock Roundup: Pipeline Updates From REGN, BIIB, AMGN and More
finance.yahoo.com - September 25 at 3:45 PM
Why Investors Are Beginning To Doubt This Biotech's R&D ProwessWhy Investors Are Beginning To Doubt This Biotech's R&D Prowess
finance.yahoo.com - September 24 at 7:25 PM
Is Regeneron Stock A Dud? Analyst Doubts Biotech's Research ProwessIs Regeneron Stock A Dud? Analyst Doubts Biotech's Research Prowess
finance.yahoo.com - September 24 at 2:25 PM
Regeneron/Sanofi Gets Positive CHMP Opinion for DupixentRegeneron/Sanofi Gets Positive CHMP Opinion for Dupixent
finance.yahoo.com - September 23 at 2:55 PM
Top Research Reports for Target, Illumina & T-Mobile USTop Research Reports for Target, Illumina & T-Mobile US
finance.yahoo.com - September 20 at 8:37 PM
Regeneron Rises After European Committee Adopts Positive Opinion on DupixentRegeneron Rises After European Committee Adopts Positive Opinion on Dupixent
finance.yahoo.com - September 20 at 3:36 PM
Regeneron, Sanofis Dupixent gets positive opinionRegeneron, Sanofi's Dupixent gets positive opinion
www.marketwatch.com - September 20 at 10:35 AM
CHMP Recommends Approval of Dupixent® (dupilumab) for Severe Chronic Rhinosinusitis with Nasal PolyposisCHMP Recommends Approval of Dupixent® (dupilumab) for Severe Chronic Rhinosinusitis with Nasal Polyposis
finance.yahoo.com - September 20 at 10:35 AM
The Lancet Publishes Results from Two Positive Phase 3 Trials of Dupixent® (dupilumab) in Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)The Lancet Publishes Results from Two Positive Phase 3 Trials of Dupixent® (dupilumab) in Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
finance.yahoo.com - September 20 at 10:35 AM
Regeneron Debuts on Prestigious Dow Jones Sustainability World Index of Most Sustainable CompaniesRegeneron Debuts on Prestigious Dow Jones Sustainability World Index of Most Sustainable Companies
finance.yahoo.com - September 18 at 11:33 AM
Educational Campaign Helps Teens and Their Caregivers Tackle Everyday Challenges of Living with Moderate-to-severe Atopic DermatitisEducational Campaign Helps Teens and Their Caregivers Tackle Everyday Challenges of Living with Moderate-to-severe Atopic Dermatitis
finance.yahoo.com - September 18 at 11:33 AM
Glaxo's Asthma Drug Nucala Gets FDA Nod for Pediatric UseGlaxo's Asthma Drug Nucala Gets FDA Nod for Pediatric Use
finance.yahoo.com - September 13 at 2:18 PM
Biotech Stock Roundup: REGN Wins Against AMGN, VRTX to Acquire Semma & MoreBiotech Stock Roundup: REGN Wins Against AMGN, VRTX to Acquire Semma & More
www.msn.com - September 6 at 6:33 AM
Regeneron (REGN) Down 5.2% Since Last Earnings Report: Can It Rebound?Regeneron (REGN) Down 5.2% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - September 6 at 6:33 AM
Esperion's Bempedoic Acid Succeeds in Phase II Diabetes StudyEsperion's Bempedoic Acid Succeeds in Phase II Diabetes Study
finance.yahoo.com - August 30 at 11:35 AM
U.S. judge rules for Sanofi in Amgen patent fightU.S. judge rules for Sanofi in Amgen patent fight
finance.yahoo.com - August 29 at 9:08 AM
U.S. judge rules for Regeneron, Sanofi in Amgen cholesterol drug patent fightU.S. judge rules for Regeneron, Sanofi in Amgen cholesterol drug patent fight
finance.yahoo.com - August 29 at 9:08 AM
U.S. District Court Invalidates Amgen Patent Claims Targeting PCSK9U.S. District Court Invalidates Amgen Patent Claims Targeting PCSK9
finance.yahoo.com - August 29 at 9:08 AM
Sanofi/Regeneron receive favorable ruling in patent dispute with AmgenSanofi/Regeneron receive favorable ruling in patent dispute with Amgen
seekingalpha.com - August 28 at 3:59 PM
Amgen Faces Trouble in the Anti-Cholesterol-Drug Battle, Analyst SaysAmgen Faces Trouble in the Anti-Cholesterol-Drug Battle, Analyst Says
finance.yahoo.com - August 28 at 3:59 PM
UPDATE 1-U.S. judge rules for Sanofi in Amgen patent fightUPDATE 1-U.S. judge rules for Sanofi in Amgen patent fight
finance.yahoo.com - August 28 at 3:59 PM
The regions largest construction project is taking shape on Regenerons campusThe region's largest construction project is taking shape on Regeneron's campus
www.bizjournals.com - August 27 at 12:11 PM
The region's largest construction project is taking shape on Regeneron's campusThe region's largest construction project is taking shape on Regeneron's campus
finance.yahoo.com - August 27 at 12:11 PM
Read This Before You Buy Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Because Of Its P/E RatioRead This Before You Buy Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Because Of Its P/E Ratio
finance.yahoo.com - August 26 at 12:10 PM
Esperion's Drugs in Review Hold Potential, Funds a ConcernEsperion's Drugs in Review Hold Potential, Funds a Concern
finance.yahoo.com - August 26 at 12:10 PM
Noteworthy Thursday Option Activity: SRE, REGN, MCDNoteworthy Thursday Option Activity: SRE, REGN, MCD
www.nasdaq.com - August 22 at 4:03 PM
Interesting REGN Put And Call Options For October 18thInteresting REGN Put And Call Options For October 18th
www.nasdaq.com - August 20 at 4:31 PM
Regeneron Announces Upcoming Investor Conference PresentationRegeneron Announces Upcoming Investor Conference Presentation
finance.yahoo.com - August 15 at 10:28 AM
Noteworthy Wednesday Option Activity: MS, REGN, ANTMNoteworthy Wednesday Option Activity: MS, REGN, ANTM
www.nasdaq.com - August 14 at 9:05 PM
Regenerons evinacumab successful in late-stage study in inherited type of high cholesterolRegeneron's evinacumab successful in late-stage study in inherited type of high cholesterol
seekingalpha.com - August 14 at 11:04 AM
Regenerons Drug To Treat Genetic Form Of Bad Cholesterol Aces Late-Stage TrialRegeneron's Drug To Treat Genetic Form Of Bad Cholesterol Aces Late-Stage Trial
www.benzinga.com - August 14 at 11:04 AM
Is Regeneron Pharmaceuticals (REGN) A Great Pick for Value Investors?Is Regeneron Pharmaceuticals (REGN) A Great Pick for Value Investors?
finance.yahoo.com - August 14 at 11:04 AM
A Promising Ebola Drug Isn’t Helping Regeneron Stock. Here’s Why.A Promising Ebola Drug Isn’t Helping Regeneron Stock. Here’s Why.
finance.yahoo.com - August 13 at 4:11 PM
Regenerons Eylea Prefilled Syringe Clears FDA HurdleRegeneron's Eylea Prefilled Syringe Clears FDA Hurdle
www.benzinga.com - August 13 at 11:42 AM
New experimental Ebola drugs are saving lives in AfricaNew experimental Ebola drugs are saving lives in Africa
finance.yahoo.com - August 12 at 3:56 PM
Regenerons REGN-EB3 shows positive effect in Ebola studyRegeneron's REGN-EB3 shows positive effect in Ebola study
seekingalpha.com - August 12 at 12:19 PM
Congo trial of Ebola treatments switches to focus on two drugsCongo trial of Ebola treatments switches to focus on two drugs
finance.yahoo.com - August 12 at 12:19 PM
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel